MPP at #AORTIC2023
2 November 2023
The Medicines Patent Pool took part in the 14th AORTIC International Conference on Cancer in Africa in Dakar from 2 to 6 November 2023. The conference brought together multidisciplinary specialists from the global cancer community to reduce the impact of cancer in Africa.
MPP participated in two sessions:
SUNDAY 5 NOVEMBER, 09:00 – 10:00
Concurrent session 4, salle 201/202
Access to medicines, how can we solve this enigma?
Facilitators and opening remarks:
- D Milner (USA)
- K Asante (South Africa), D Ejoh (Nigeria) | Treatment disparities across and within countries – Why do we need to speak about access to medicines?
- V Vanderpuye (Ghana) | The clinician perspective: why is innovation so relevant in the oncology field? Innovations in diagnosis, treatment, and care can improve outcomes and quality of life for patients
- G Segafredo (Switzerland) | Voluntary license as a mechanism to improve availability and affordability of cancer medicines (even if patented)
- G Nakigudde (Uganda) | A patient’s perspective on how good universal access can curb financial toxicity: a case study from Uganda
- S Meyer (South Africa) | Country experience: South Africa (Trastuzumab)
- K Asante (South Africa) | Closing remarks
SUNDAY 5 NOVEMBER, 12:40 – 13:40
Concurrent Session 2, Salle Ovale
Can we achieve faster and more sustainable access to innovative cancer medicines? Lessons learned from access to innovative HIV medicines.
Introduction and moderation:
- Chair: Miriam Mutebi (Kenya)
Panelists and respective topic:
- Public health oriented Voluntary Licensing – what is it and what it achieved in the HIV space. – Esteban Burrone, Medicines Patent Pool (Switzerland)
- How can international health partners work together to ensure prompt access to innovative cancer medicines? – Dan Milner, Access To Oncology Medicines (ATOM) Coalition (USA)
- How to support countries in selecting cancer medicines to procure? And what else could be done to facilitate the procurement and uptake of innovative medicines at the country level? – Vivienne Mulema, Clinton Health Access Initiative (CHAI) (Uganda)
- What can be done at country level to ensure prompt access to innovative cancer medicines? – Susan Citonje Msadabwe-Chikuni (Zambia)
- What can patient advocates do at country level to accelerate equitable access? – Gertrude Nakigudde (Uganda)
WE HAD A BOOTH #7 IN THE EXHIBITION AREA